Growth Metrics

Rigel Pharmaceuticals (RIGL) Amortizatization of Intangibles: 2017-2025

Historic Amortizatization of Intangibles for Rigel Pharmaceuticals (RIGL) over the last 9 years, with Sep 2025 value amounting to $467,000.

  • Rigel Pharmaceuticals' Amortizatization of Intangibles rose 576.81% to $467,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year increase of 70.71%. This contributed to the annual value of $709,000 for FY2024, which is 48.02% up from last year.
  • Rigel Pharmaceuticals' Amortizatization of Intangibles amounted to $467,000 in Q3 2025, which was up 86.80% from $250,000 recorded in Q2 2025.
  • Rigel Pharmaceuticals' Amortizatization of Intangibles' 5-year high stood at $467,000 during Q3 2025, with a 5-year trough of -$116,000 in Q4 2021.
  • Over the past 3 years, Rigel Pharmaceuticals' median Amortizatization of Intangibles value was $190,000 (recorded in 2025), while the average stood at $190,455.
  • Per our database at Business Quant, Rigel Pharmaceuticals' Amortizatization of Intangibles slumped by 690.00% in 2022 and then skyrocketed by 1,266.67% in 2023.
  • Quarterly analysis of 5 years shows Rigel Pharmaceuticals' Amortizatization of Intangibles stood at -$116,000 in 2021, then spiked by 254.31% to $179,000 in 2022, then surged by 45.25% to $260,000 in 2023, then climbed by 6.15% to $276,000 in 2024, then soared by 576.81% to $467,000 in 2025.
  • Its Amortizatization of Intangibles stands at $467,000 for Q3 2025, versus $250,000 for Q2 2025 and $190,000 for Q1 2025.